A group of members of European parliament with a speacial interest in breast cancer has cut its ties with a breast cancer advocacy group, Europa Donna, because of the group’s acceptance of financial support from drug companies. “We at EPGBC (European parliamentary group on breast cancer) reject further co-operation with Europa Donna because the board of the European lobby group became more and more a lobby instrument for the market interests of the big pharmaceutical companies”.